ORIGINAL PAPER
Medium-term prognosis of survival and hospitalization of patients after permanent pacemaker implantation based on BNP, high-sensitivity troponin T, and left atrium volume index
1
Intensive Cardiac Care Unit, Świętokrzyskie Cardiology Centre, Regional Hospital, Kielce, Poland
2
The Institute of Medical Sciences, The Kochanowski University, Kielce, Poland
3
Central Laboratory, Regional Hospital, Kielce, Poland
Submission date: 2017-05-23
Final revision date: 2017-08-21
Acceptance date: 2017-10-20
Publication date: 2017-12-31
Medical Studies 2017;33(4):262-269
KEYWORDS
TOPICS
ABSTRACT
Introduction: Determination of predictors of survival and hospitalization can optimise a medical care of patient with permanent pacemaker.
Aim of the research: Use of the B-type natriuretic peptide (BNP), high-sensitivity troponin T (TnT hs), and left atrial volume index (LAVI) to control survival and hospitalizations due to cardiovascular causes in patients after pacemaker implantation.
Material and methods: The study covered a sample of 123 patients qualified for pacemaker implantation. During 23-month observation, cyclic BNP, TnT hs and LAVI examinations were performed. Mortality and hospitalization rate in groups with normal and elevated values were assesed using Kaplan-Meier curves.
Results: A statistical relationship was observed between survival and increased initial BNP plasma level (log-rank test = 2.11, p < 0.05). Significantly higher frequency of hospitalizations was observed with a higher initial BNP plasma level (log-rank test = 2.01, p < 0.05). No statistically significant relationships were found between the TnT hs concentration and the duration of survival and hospitalizations. A strong tendency was confirmed (p < 0.10) towards a higher probability of the survival of patients with low values of LAVI, compared to patients with high values of LAVI.
Conclusions: Results of the study conducted in regional centre (over 1000 implantations per year) confirmed that BNP peptide is an important indicator of survival and hospitalization due to cardiovascular causes after permanent pacemaker implantation. From among the 3 parameters examined: BNP, TnT hs LAVI, only BNP peptide and LAVI may be justified in the evaluation of patients after pacemaker implantation. Determination of BNP for evaluation medium-term prognosis of survival and hospitalization may be considered during routine pacemaker control visit.
Aim of the research: Use of the B-type natriuretic peptide (BNP), high-sensitivity troponin T (TnT hs), and left atrial volume index (LAVI) to control survival and hospitalizations due to cardiovascular causes in patients after pacemaker implantation.
Material and methods: The study covered a sample of 123 patients qualified for pacemaker implantation. During 23-month observation, cyclic BNP, TnT hs and LAVI examinations were performed. Mortality and hospitalization rate in groups with normal and elevated values were assesed using Kaplan-Meier curves.
Results: A statistical relationship was observed between survival and increased initial BNP plasma level (log-rank test = 2.11, p < 0.05). Significantly higher frequency of hospitalizations was observed with a higher initial BNP plasma level (log-rank test = 2.01, p < 0.05). No statistically significant relationships were found between the TnT hs concentration and the duration of survival and hospitalizations. A strong tendency was confirmed (p < 0.10) towards a higher probability of the survival of patients with low values of LAVI, compared to patients with high values of LAVI.
Conclusions: Results of the study conducted in regional centre (over 1000 implantations per year) confirmed that BNP peptide is an important indicator of survival and hospitalization due to cardiovascular causes after permanent pacemaker implantation. From among the 3 parameters examined: BNP, TnT hs LAVI, only BNP peptide and LAVI may be justified in the evaluation of patients after pacemaker implantation. Determination of BNP for evaluation medium-term prognosis of survival and hospitalization may be considered during routine pacemaker control visit.
REFERENCES (27)
2.
Kowalski O. Biała księga elektroterapii serca w Polsce. Sekcja Rytmu Serca Polskie Towarzystwo Kardiologiczne 2016; 7.
3.
Janion M. Sprawozdanie Konsultanta Wojewódzkiego w dziedzinie kardiologii dla województwa świętokrzyskiego za 2016 r. Kielce 2016; 2-3.
4.
Palazzuoli A, Antonelli G, Quatrini I, Nuti R. Natriuretic peptides in heart failure: where we are, where we are going. Intern Emerg Med 2011; 6: 63-8.
5.
Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators. Rapid measurement of B type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
6.
Mueller C, Laule-Kilian K, Schindler C, Klima T, Frana B, Rodriguez D, Scholer A, Christ M, Perruchoud AP. Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea. Arch Intern Med 2006; 166: 1081-1087.
7.
Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E; Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009; 361: 2538-2547.
8.
Lazzeroni D, Gaibazzi N, Bini M, Bussolati G, Camaiora U, Cassi R, Geroldi S, Ugolotti PT, Brambilla L, Brambilla V, Castiglioni P, Coruzzi P. Prognostic value of new left atrial volume index severity partition cutoffs after cardiac rehabilitation program in patients undergoing cardiac surgery. Cardiovasc Ultrasound 2016; 14: 35.
9.
Biteker M, Kayataş K, Başaran Ö. The role of left atrial volume index in patients with a first-ever acute ischemic stroke. J Stroke Cerebrovasc Dis 2017; 26: 321-326.
10.
Toufan M, Kazemi B, Molazadeh N. The significance of the left atrial volume index in prediction of atrial fibrillation recurrence after electrical cardioversion. J Cardiovasc Thorac Res 2017; 9: 54-59.
11.
Cooley DA. In memoriam: tribute to Ake Senning, pioneering cardiovascular surgeon. Texas Heart Inst J 2000; 27: 234.
13.
Elmqvist R. Review of early pacemaker development. Pacing Clin Electrophysiol 1978; 1: 535-536.
14.
Furman S. The early history of cardiac pacing. Pacing Clin Electrophysiol 2003; 26: 2023-2032.
15.
Udo EO, van Hemel NM, Zuithoff NP, Doevendans PA, Moons KG. Prognosis of the bradycardia pacemaker recipient assessed at first implantation: a nationwide cohort study. Heart 2013; 99: 1573-1578.
16.
Pyatt JR, Somauroo JD, Jackson D, Grayson AD, Osula S, Aggarwal RK, Charles RG, Connelly DT. Long-term survival after permanent pacemaker implantation: analysis of predictors for increased mortality. Europace 2002; 4: 113-119.
17.
Krzemień-Wolska K, Tomasik A, Nowalany-Kozielska E, Jacheć W. Prognosis of patients with implanted pacemakers in 4-year follow-up. Herz 2017; doi: 10.1007/s00059-017-4561-6.
18.
Shen WK, Hammill SC, Hayes DL, Packer DL, Bailey KR, Ballard DJ, Gersh BJ. Long- term survival after pacemaker implantation for heart block in patients > or = 65 years. Am J Cardiol 1994; 74: 560-564.
19.
Brevik K, Ohm OJ, Segadal L. Sick sinus syndrome treated with permanent pacemaker in 109 patients: a follow-up study. Acta Med Scand 1979; 206: 153-159.
20.
Skagen K, Fischer Hansen J. The long-term prognosis for patients with sinoatrial block treated with permanent pacemaker. Acta Med Scan 1976; 199: 13-15.
21.
Brandt NH, Kirkfeldt RE, Nielsen JC, Mortensen LS, Jensen GVH, Johansen JB, Haugan K. Single lead atrial vs. dual chamber pacing in sick sinus syndrome: extended register-based follow-up in the DANPACE trial. Europace 2016 Dec 29. pii: euw364.
22.
Gierula J, Cubbon RM, Jamil HA, Byrom RJ, Waldron ZL, Pavitt S, Kearney MT, Witte KK. Patients with long-term permanent pacemakers have a high prevelance of left ventricular dysfunction. J Cardiovasc Med 2015; 16: 743-750.
23.
Kafara M, Bogacki P, Lakalowska-Pieła M, Lelakowski J. Patients with implanted pacemakers in the primary hospital and stay under the care of an outpatient cardiology clinic – differences in comparison with the reference center. Pol Merkur Lek 2014; 36: 160-164.
24.
Nichols CI, Vose JG, Mittal S. Incidence and cost related to lead damage occurring within the first year after a cardiac implantable electronic device replacement procedure. J Am Heart Assoc 2016; 5: e002813.
25.
Sielski J, Grabowska U. Are brain natriuretic peptide levels, high-sensitivity troponin T assay and certain left atrial echocardiographic parameters useful in the evaluation of patients with permanent pacemakers? Eur J Cardiovasc Med doi: 10.5083/ejcm.20424884.121.
26.
Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation 2014; 130: 1037-1043.
27.
Sridhar AR, Yarlagadda V, Yeruva MR, Kanmanthareddy A, Vallakati A, Dawn B, Lakkireddy D. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study. Europace 2015; 17: 1548-1554.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
